Recurrences, vaccinations and long-term symptoms in GBS and CIDP. In a survey conducted in the Netherlands, people who had GBS in the past were queried about whether they had another GBS episode following seasonal flu vaccine, and the answer was an unequivocal 'No' in over 100 recovered GBS persons, many of whom received multiple flu vaccines over many years (Kuitwaard et al. The Journal of Infectious Diseases, jiaa544, ). Guillain-Barré Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence. Since then, the only vaccine associated with GBS has been the flu vaccine at a rate of 1 extra case of GBS/1,000,000 vaccinees, that is, 21 cases when 20 are expected (Salmon et al. GBS was associated with the 1976/1977 swine flu vaccine at a rate of about 1 case/100,000 vaccinees. "On the television show, you stated that people who had GBS in the past should avoid the COVID vaccines as they may cause another episode of GBS. Your statement is already all over the internet with many believing it to be true and acting accordingly. "As clinician/scientists who have spent careers studying GBS, we are concerned that your statement on the 'New Normal' television show about GBS and the COVID vaccine will have unintended consequences. Jacobs, MD, PhD Erasmus MC, University Medical Hospital, Rotterdam, The Netherlands Richard A Lewis, MD Cedars-Sinai Medical Center, Los Angeles, CA USA Sonja Leonhard, MD Erasmus MC University Medical Center, Rotterdam, The Netherlands Michael P Lunn, FRCP, PhD National Hospital for Neurology and Neurosurgery, London, UK Eduardo Nobile-Orazio, MD, PhD Milan University, Milan, Italy Luis Querol, MD, PhD Hospital de la Santa Creu i Sant Pau, Barcelona, Spain Pieter A van Doorn, MD, PhD Erasmus MC, University Medical Hospital, Rotterdam, The Netherlands Hugh Willison, MD, PhD Institute of Infection, Immunity and Inflammation, University of Glasgow, UK GBS/CIDP Foundation Kenneth C Gorson, MD Tufts University, Boston, MA USA Thomas Harbo, MD, PhD Aarhus University Hospital, Aarhus, Denmark Richard Hughes, MD King's College, London, UK Bart C. Donofrio, M.D., Chair, Medical Advisory Board. Cornblath, MD Johns Hopkins University School of Medicine, Baltimore, MD USA Peter D. This letter has been authored, approved and signed by the following physicians:ĭavid R. A.S. Fauci, has been authored as referenced.
![clarify covid 19 clarify covid 19](https://www.santeservicebayonne.fr/fileadmin/2-images/actualites/Covid-19_1erSignes.jpg)
Fauci, Director of NIAID, NIH, regarding the COVID-19 vaccine as it pertains to the GBS community, and to further clarify COVID-19 vaccine confusion among patients & caregivers, the following open letter to Dr. In response to a recent public statement made by Dr. The GBS|CIDP Foundation International provides up-to-date resources, publications and statements that are vetted through the Foundation's Global Medical Advisory Board (GMAB), and key opinion leaders from the GBS|CIDP Medical Community worldwide. 21, 2020 /PRNewswire/ - Confusion regarding the COVID-19 vaccination is growing among patients and caregivers coping with Guillain-Barre Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy.